John R. Pinion II

Chief Quality Officer and Executive Vice President of Translational Sciences

Other

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	Ultragenyx Pharmaceutical Inc. (RARE)	Chief Quality Officer and Executive Vice President, Translational Sciences	$570,366	—	$2,084,548	$1,121,271	$339,768	$13,800	$4,129,753
2023	Ultragenyx Pharmaceutical Inc. (RARE)	Chief Quality Officer and Executive Vice President, Translational Sciences	$552,092	—	$2,169,750	$1,020,050	$294,761	$13,200	$4,049,853
2022	Ultragenyx Pharmaceutical Inc. (RARE)	Chief Quality Officer and Executive Vice President, Translational Sciences	$533,315	—	$2,007,768	$892,550	$260,678	$12,200	$3,706,511
2021	Ultragenyx Pharmaceutical Inc. (RARE)	Chief Quality Officer and Executive Vice President, Translational Sciences	$509,939	—	$1,653,212	$866,427	$224,942	$8,700	$3,263,220
2020	Ultragenyx Pharmaceutical Inc. (RARE)	Chief Quality Officer and Executive Vice President, Translational Sciences	$480,063	—	$723,432	$707,007	$267,138	—	$2,177,640
2019	Ultragenyx Pharmaceutical Inc. (RARE)	Chief Quality Officer and Executive Vice President, Translational Sciences	$447,690	—	$1,756,300	$923,578	$205,490	—	$3,333,238
2018	Ultragenyx Pharmaceutical Inc. (RARE)	Chief Quality Officer and Executive Vice President, Translational Sciences	$430,320	—	$217,935	$728,443	$188,030	$36,346	$1,601,074
2017	Ultragenyx Pharmaceutical Inc. (RARE)	Chief Quality Officer and Executive Vice President, Translational Sciences	$412,568	—	$308,603	$991,208	$170,459	$36,491	$1,919,329

Earnings-call appearances

No earnings-call appearances recorded yet.